Precision BioSciences Inc (DTIL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.47+1.36%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DTIL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | — | 34.3 | 68.7 | 48.7 | 25.1 | 115.5 | 24.3 | 1,070.0 |
| Total Revenues | — | — | — | — | — | — | — | 1,070.0 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 53.3 | 54.2 | 59.6 | 53.4 | 46.1 | 115.2 | 98.1 | 82.4 |
| Operating Income | (36.4) | (52.1) | (26.2) | (43.7) | (62.3) | (39.4) | (109.8) | (87.2) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 1.4 | 1.8 | 2.2 | 1.1 | 0.1 | — | 0.2 |
| Interest & Investment Income | — | — | — | — | — | 0.2 | 0.8 | 4.3 |
| Net Interest Expenses | — | — | — | — | — | (0.1) | — | (4.1) |
| Asset Writedown | — | 0.0 | — | — | 10.8 | — | — | — |
| EBT, Incl. Unusual Items | — | (45.7) | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | 0.0 | — |
| Net Income | ||||||||
| Net Income | (52.7) | (45.7) | 7.2 | (61.3) | (111.6) | (30.6) | (109.0) | (92.9) |
| Per Share | ||||||||
| Basic EPS | (2.04) | (3.56) | 1.05 | (15.96) | (38.10) | (0.52) | — | — |
| Diluted EPS | (2.04) | (3.56) | 1.04 | (15.96) | (38.10) | (0.52) | — | — |
| Basic Weighted Avg Shares | 25.9 | 12.8 | 6.8 | 3.8 | 2.9 | 58.7 | — | — |
| Diluted Weighted Avg Shares | 25.9 | 12.8 | 6.9 | 3.8 | 2.9 | 58.7 | — | — |
| Supplemental | ||||||||
| EBITDA | — | (50.7) | (22.8) | (36.9) | (54.5) | (30.4) | (101.1) | (81.9) |
| EBIT | (36.4) | (52.1) | (26.2) | (43.7) | (62.3) | (39.4) | (109.8) | (87.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.